Serum Calretinin as a Biomarker in Malignant Mesothelioma
The early diagnosis of malignant mesothelioma (MM) could improve the prognosis of MM patients. To confirm an MM diagnosis, an immunohistochemical analysis of several tumor tissue markers, including calretinin, is currently required. Our aim is to evaluate serum calretinin as a potential biomarker in...
Enregistré dans:
Auteurs principaux: | Cita Zupanc, Alenka Franko, Danijela Štrbac, Metoda Dodič Fikfak, Viljem Kovač, Vita Dolžan, Katja Goričar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/edcf4814866c47509e6a48e4eb336d3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma
par: Veronica Filetti, et autres
Publié: (2021) -
Modern management of malignant pleural mesothelioma
par: Patel SC, et autres
Publié: (2016) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
par: Sara Ricciardi, et autres
Publié: (2021) -
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
par: Giuseppe Mangiameli, et autres
Publié: (2021) -
Pain management in patients with malignant mesothelioma: challenges and solutions
par: Saunders J, et autres
Publié: (2019)